Side-by-side comparison of AI visibility scores, market position, and capabilities
Sarasota FL vertical software holding company (NASDAQ: ROP) at $7.04B 2024 revenue (+14%) and record $2.3B free cash flow; $3.6B acquisitions in 2024 (Procare Solutions, Transact Campus) competing with Constellation Software.
Roper Technologies, Inc. is a Sarasota, Florida-based diversified vertical software holding company — publicly traded on the NASDAQ (NASDAQ: ROP) as an S&P 500, NASDAQ 100, and Fortune 1000 component — acquiring and operating market-leading software and technology companies that serve niche vertical markets with high switching costs and recurring revenue models, generating $7.04 billion in revenue and a record $2.3 billion in free cash flow in fiscal year 2024. CEO Neil Hunn has led Roper's software transformation strategy, building a portfolio of 40+ vertical software businesses across three segments: Application Software (55% of 2024 revenue, including Aderant for legal management, Deltek for project-based businesses serving 23,000+ organizations, Vertafore for insurance distribution serving 20,000+ agencies, and Procare Solutions for early childhood education — acquired in 2024); Network Software (21%, including ConstructConnect, DAT Solutions freight marketplace, and iPipeline); and Technology Enabled Products (24%, including Verathon medical devices, Neptune water meter technology, and CIVCO Medical Solutions). In 2024, Roper deployed $3.6 billion on acquisitions including Procare Solutions and Transact Campus, maintaining $5+ billion in available M&A capital. Founded in 1890 as a home appliance and industrial manufacturer by George D. Roper, the company's strategic reinvention under former CEO Brian Jellison (early 2000s) into vertical software represents one of the most successful business model transformations in US industrial history.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.